News
In just eight years, the NIH National Institute of Allergy and Infectious Diseases moved from identifying an ultra-rare genetic disorder, CD55 deficiency, hyperactivation of the complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE) to FDA approval of its first treatment option
The OTT is pleased to announce that the annual report for Fiscal Year 2011 is now available for downloading. Click the icon below to download and view the report.
The Federal Laboratory Consortium for Technology Transfer Mid-Atlantic Region (FLC-MAR) has selected Samuel E. Bish, Ph.D., a Licensing & Patenting Manager in the Cancer Branch of the NIH Office of Technology Transfer (OTT), as the 2011 winner of its Rookie of the Year Award. The FLC-MAR Rookie of
The U.S. Department of State has gratefully acknowledged the contributions by staff members from the NIH Office of Technology Transfer (OTT) who assisted with the recently concluded project on “Technology Transfer and Research Commercialization in the U.S.” that was organized for a group of leading